Development of venetoclax performance using its new derivatives on BCL‐2 protein inhibition
Sign Up to like & getrecommendations! Published in 2022 at "Cell Biochemistry and Function"
DOI: 10.1002/cbf.3760
Abstract: Cancer cells are resistant to apoptosis and this is one of the most obvious symptoms of cancer in humans. One of the most exciting strategies for treating cancer is to design regulators that increase cell… read more here.
Keywords: performance using; performance; using new; venetoclax performance ... See more keywords